Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pheochromocytoma × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Prostatic Neoplasms 7 Neoplasms 7 Colorectal Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Venous Thromboembolism 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm Metastasis 2 Motor Activity 2 Melanoma 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Burkitt Lymphoma 2 Brain Neoplasms 2

Interventions

3-Iodobenzylguanidine 4 Phenoxybenzamine 2 Ifosfamide 2 Filgrastim 2 Everolimus 2 Doxorubicin 2 Doxazosin 2 Dexmedetomidine 2 vatalanib 1 temsirolimus 1 pegfilgrastim 1 lenvatinib 1 fostamatinib 1 cabozantinib 1 atezolizumab 1 Vinorelbine 1 Temozolomide 1 Stem Cell Transplantation 1 Sirolimus 1 Saline Solution 1 Radiotherapy 1 Oxaliplatin 1 Observation 1 Melphalan 1 Leucovorin 1 Iodine-131 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Floxuridine 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05082311 2022-02-10

PheoCard

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Cardiomyopathies, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡